Erratum: Conditional transgenic expression of TIR-domain-containing adaptor-inducing interferon-β (TRIF) in the adult mouse heart is protective in acute viral myocarditis (Basic Research in Cardiology DOI: 10.1007/s00395-011-0226-4);Conditional transgenic expression of TIR-domain-containing adaptor-inducing interferon-β (TRIF) in the adult mouse heart is protective in acute viral myocarditis

Basic Research in Cardiology

Volumn 106, Issue 6, 2011, Pages 1159-1171

  Xu, Zhaohui ^a   Desai, Moreshwar ^a   Philip, Joseph ^a   Sivsubramanian, Natarajan ^a   Bowles, Neil E ^b   Vallejo, Jesus G ^a  

^a TEXAS CHILDREN S HOSPITAL   (United States)

^b UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

Author keywords

Cytokines; Infection; Inflammation; Innate immunity; Myocardial function

Indexed keywords

CYTOKINE; DOXYCYCLINE; TOLL LIKE RECEPTOR ADAPTOR MOLECULE 1;

ACUTE DISEASE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARDIOVIRUS INFECTION; CELL INFILTRATION; CONTROLLED STUDY; CYTOKINE RESPONSE; DISEASE SEVERITY; ENCEPHALOMYOCARDITIS VIRUS; FEMALE; HEART FUNCTION; HEART INJURY; HEART MUSCLE CELL; HEART PROTECTION; HISTOPATHOLOGY; INFECTION PREVENTION; MALE; MOUSE; NONHUMAN; PHENOTYPE; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; SIGNAL TRANSDUCTION; TRANSGENICS; UPREGULATION; VIRUS LOAD; VIRUS MYOCARDITIS; VIRUS REPLICATION;

EID: 84856734627     PISSN: 03008428     EISSN: 14351803     Source Type: Journal    
DOI: 10.1007/s00395-011-0234-4     Document Type: Erratum

References (36)

1. Baumgarten G, Knuefermann P, Nozaki N, Sivasubramanian N, Mann DL, Vallejo JG (2001) In vivo expression of proinflammatory mediators in the adult heart after endotoxin administration: the role of toll-like receptor-4. J Infect Dis 183:1617-1624. doi:10.1086/320712 (Pubitemid 32466699)
2. Boengler K, Hilfiker-Kleiner D, Drexler H, Heusch G, Schulz R (2008) The myocardial JAK/STAT pathway: from protection to failure. Pharmacol Ther 120:172-185. doi:10.1016/j.pharmthera. 2008.08.002
3. Chao W (2009) Toll-like receptor signaling: a critical modulator of cell survival and ischemic injury in the heart. Am J Physiol Heart Circ Physiol 296:H1-H12. doi:10.1152/ajpheart.00995. 2008
4. Deonarain R, Cerullo D, Fuse K, Liu PP, Fish EN (2004) Protective role for interferon-beta in coxsackievirus B3 infection. Circulation 110:3540-3543. doi:10.1161/01. CIR.0000136824. 73458.20 (Pubitemid 39612568)
5. Desai MS, Mariscalco MM, Tawil A, Vallejo JG, Smith CW (2008) Atherogenic diet-induced hepatitis is partially dependent on murine TLR4. J Leukoc Biol 83:1336-1344. doi:10.1189/jlb.0607390 (Pubitemid 351960312)
6. Fairweather D, Yusung S, Frisancho S, Barrett M, Gatewood S, Steele R, Rose NR (2003) IL-12 receptor beta 1 and toll-like receptor 4 increase IL-1 beta-and IL-18-associated myocarditis and coxsackievirus replication. J Immunol 170:4731-4737. http://jimmunol.org/content/170/9/4731.full.pdf?html (Pubitemid 36519981)
7. Feldman AM, McNamara D (2000) Myocarditis. N Engl J Med 343:1388-1398. doi:10.1056/NEJM200011093431908
8. Fuse K, Chan G, Liu Y, Gudgeon P, Husain M, Chen M, Yeh WC, Akira S, Liu PP (2005) Myeloid differentiation factor-88 plays a crucial role in the pathogenesis of Coxsackievirus B3-induced myocarditis and influences type I interferon production. Circulation 112:2276-2285. doi:10.1161/CIRCULATIONAHA. 105.536433 (Pubitemid 41464570)
9. Gitlin L, Barchet W, Gilfillan S, Cella M, Beutler B, Flavell RA, Diamond MS, Colonna M (2006) Essential role of mda-5 in type I IFN responses to polyriboinosinic: polyribocytidylic acid and encephalomyocarditis picornavirus. Proc Natl Acad Sci USA 103:8459-8464. doi:10.1073/pnas.0603082103 (Pubitemid 43838477)
10. Gorbea C, Makar KA, Pauschinger M, Pratt G, Bersola JL, Varela J, David RM, Banks L, Huang CH, Li H, Schultheiss HP, Towbin JA, Vallejo JG, Bowles NE (2010) A role for toll-like receptor 3 variants in host susceptibility to enteroviral myocarditis and dilated cardiomyopathy. J Biol Chem 285:23208-23223. doi: 10.1074/jbc. M109.047464
11. Hardarson HS, Baker JS, Yang Z, Purevjav E, Huang CH, Alexopoulou L, Li N, Flavell R, Bowles NE, Vallejo JG (2006) Toll-like receptors 3 is an essential component of the innate stress response in virus-induced cardiac injury. Am J Physiol Heart Circ Physiol 292:H251-H258. doi:10.1152/ajpheart.00398.2006 (Pubitemid 46105186)
12. Hennessy EJ, Parker AE, O'Neill LA (2010) Targeting toll-like receptors: emerging therapeutics? Nat Rev Drug Discov 9:293-307. doi:10.1038/nrd3203
13. Hoebe K, Du X, Georgel P, Janssen E, Tabeta K, Kim SO, Goode J, Lin P, Mann N, Mudd S, Crozat K, Sovath S, Han J, Beutler B (2003) Identification of Lps2 as a key transducer of MyD88-independent TIR signalling. Nature 424:743-748. doi:10.1038/nature01889 (Pubitemid 37021696)
14. Huang CH, Vallejo JG, Kollias G, Mann DL (2009) Role of the innate immune system in acute viral myocarditis. Basic Res Cardiol 104:228-237. doi:10.1007/s00395-008-0765-5
15. Kato H, Takeuchi O, Sato S, Yoneyama M, Yamamoto M, Matsui K, Uematsu S, Jung A, Kawai T, Ishii KJ, Yamaguchi O, Otsu K, Tsujimura T, Koh CS, Sousa Reis E, Matsuura Y, Fujita T, Akira S (2006) Differential roles of MDA5 and RIG-I helicases in the recognition of RNA viruses. Nature 441:101-105. doi:10.1038/nature04734
16. Kleinbongard P, Heusch G, Schulz R (2010) TNFalpha in atherosclerosis, myocardial ischemia/reperfusion and heart failure. Pharmacol Ther 127:295-314. doi:10.1016/j.pharmthera.2010.05. 002
17. Knuefermann P, Sakata Y, Baker JS, Huang CH, Sekiguchi K, Hardarson HS, Takeuchi O, Akira S, Vallejo JG (2004) Toll-like receptor 2 mediates Staphylococcus aureus-induced myocardial dysfunction and cytokine production in the heart. Circulation 110:3693-3698. doi:10.1161/01. CIR.0000143081.13042.04 (Pubitemid 39665259)
18. Martinez J, Huang X, Yang Y (2008) Direct action of type I IFN on NK cells is required for their activation in response to vaccinia viral infection in vivo. J Immunol 180:1592-1597. http://www.jimmunol.org.ezproxyhost.library. tmc.edu/content/180/3/1592.long
19. Medzhitov R, Janeway CA Jr (1997) Innate immunity: the virtues of a nonclonal system of recognition. Cell 91:295-298. doi: 10.1016/S0092-8674(00) 80412-2 (Pubitemid 27467959)
20. Mersmann J, Habeck K, Latsch K, Zimmermann R, Jacoby C, Fischer JW, Hartmann C, Schrader J, Kirschning CJ, Zacharowski K (2010) Left ventricular dilation in toll-like receptor 2 deficient mice after myocardial ischemia/reperfusion through defective scar formation. Basic Res Cardiol. doi: 10.1007/s00395-010-0127-y
21. Mukherjee A, Morosky SA, Delorme-Axford E, Dybdahl-Sissoko N, Oberste MS, Wang T, Coyne CB (2011) The coxsackievirus B 3C protease cleaves MAVS and TRIF to attenuate host type I interferon and apoptotic signaling. PLoS Pathog 7:e1001311. doi: 10.1371/journal.ppat.1001311
22. Negishi H, Osawa T, Ogami K, Ouyang X, Sakaguchi S, Koshiba R, Yanai H, Seko Y, Shitara H, Bishop K, Yonekawa H, Tamura T, Kaisho T, Taya C, Taniguchi T, Honda K (2008) A critical link between toll-like receptor 3 and type II interferon signaling pathways in antiviral innate immunity. Proc Natl Acad Sci USA 105:20446-20451. doi:10.1073/pnas.0810372105
23. Riad A, Westermann D, Zietsch C, Savvatis K, Becher PM, Bereswill S, Heimesaat MM, Lettau O, Lassner D, Dorner A, Poller W, Busch M, Felix SB, Schultheiss HP, Tschope C (2011) TRIF is a critical survival factor in viral cardiomyopathy. J Immunol 186:2561-2570. doi:10.4049/jimmunol.1002029
24. Satoh M, Nakamura M, Akatsu T, Iwasaka J, Shimoda Y, Segawa I, Hiramori K (2003) Expression of toll-like receptor 4 is associated with enteroviral replication in human myocarditis. Clin Sci (Lond) 104:577-584. doi:10.1042/CS20020263 (Pubitemid 36713847)
25. Satoh T, Kato H, Kumagai Y, Yoneyama M, Sato S, Matsushita K, Tsujimura T, Fujita T, Akira S, Takeuchi O (2010) LGP2 is a positive regulator of RIG-I-and MDA5-mediated antiviral responses. Proc Natl Acad Sci USA 107:1512-1517. doi:10.1073/pnas.0912986107
26. Seo SU, Kwon HJ, Song JH, Byun YH, Seong BL, Kawai T, Akira S, Kweon MN (2010) MyD88 signaling is indispensable for primary influenza A virus infection but dispensable for secondary infection. J Virol 84:12713-12722. doi:10.1128/JVI.01675-10
27. Shimamoto A, Chong AJ, Yada M, Shomura S, Takayama H, Fleisig AJ, Agnew ML, Hampton CR, Rothnie CL, Spring DJ, Pohlman TH, Shimpo H, Verrier ED (2006) Inhibition of toll-like receptor 4 with eritoran attenuates myocardial ischemia-reperfusion injury. Circulation 114:I270-I274. doi:10.1161/CIRCUL ATIONAHA.105.000901 (Pubitemid 44297162)
28. Tanaka T, Kanda T, McManus BM, Kanai H, Akiyama H, Sekiguchi K, Yokoyama T, Kurabayashi M (2001) Overexpression of interleukin-6 aggravates viral myocarditis: impaired increase in tumor necrosis factor-alpha. J Mol Cell Cardiol 33:1627-1635. doi:10.1006/jmcc.2001.1428 (Pubitemid 32844221)
29. Valeur HS, Valen G (2009) Innate immunity and myocardial adaptation to ischemia. Basic Res Cardiol 104:22-32. doi: 10.1007/s00395-008-0756-6
30. Voigt A, Bartel K, Egerer K, Trimpert C, Feist E, Gericke C, Kandolf R, Klingel K, Kuckelkorn U, Stangl K, Felix SB, Baumann G, Kloetzel PM, Staudt A (2010) Humoral anti-proteasomal autoimmunity in dilated cardiomyopathy. Basic Res Cardiol 105:9-18. doi:10.1007/s00395-009-0061-z
31. Wada H, Saito K, Kanda T, Kobayashi I, Fujii H, Fujigaki S, Maekawa N, Takatsu H, Fujiwara H, Sekikawa K, Seishima M (2001) Tumor necrosis factor-alpha (TNF-alpha) plays a protective role in acute viralmyocarditis in mice: a study using mice lacking TNF-alpha. Circulation 103:743-749. http://circ.ahajournals. org/cgi/reprint/103/5/743 (Pubitemid 32144205)
32. Wessely R, Klingel K, Knowlton KU, Kandolf R (2001) Cardioselective infection with coxsackievirus B3 requires intact type I interferon signaling-implications for mortality and early viral replication. Circulation 103:756-761. http://circ.ahajournals.org/cgi/reprint/103/5/743 (Pubitemid 32144207)
33. Yamamoto M, Sato S, Mori K, Hoshino K, Takeuchi O, Takeda K, Akira S (2002) Cutting edge: a novel Toll/IL-1 receptor domain-containing adapter that preferentially activates the IFNbeta promoter in the toll-like receptor signaling. J Immunol 169:6668-6672. http://jimmunol.org/content/169/12/6668.full (Pubitemid 36899248)
34. Yasukawa H, Yajima T, Duplain H, Iwatate M, Kido M, Hoshijima M, Weitzman MD, Nakamura T, Woodard S, Xiong D, Yoshimura A, Chien KR, Knowlton KU (2003) The suppressor of cytokine signaling-1 (SOCS1) is a novel therapeutic target for enterovirus-induced cardiac injury. J Clin Invest 111:469-478. doi:10.1172/JCI16491 (Pubitemid 36228004)
35. Yuan J, Liu Z, Lim T, Zhang H, He J, Walker E, Shier C, Wang Y, Su Y, Sall A, McManus B, Yang D (2009) CXCL10 inhibits viral replication through recruitment of natural killer cells in coxsackievirus B3-induced myocarditis. Circ Res 104:628-638. doi:10.1161/CIRCRESAHA.108.192179
36. Zaragoza C, Ocampo C, Saura M, Leppo M, Wei XQ, Quick R, Moncada S, Liew FY, Lowenstein CJ (1998) The role of inducible nitric oxide synthase in the host response to Coxsackievirus myocarditis. Proc Natl Acad Sci USA 95:2469-2474. doi: 10.1073/pnas.95.5.2469 (Pubitemid 28145965)